Recent Advances in Liver Cirrhosis Related Complications

Erscheinungsjahr 2025
ISBN: 978-0-443-21938-2
Verlag: Elsevier Science

Buch, Englisch, 336 Seiten, Format (B × H): 216 mm x 276 mm

Recent Advances in Liver Cirrhosis Related Complications provides comprehensive coverage on the contemporary management of liver cirrhosis related complications and future directions for the field. Content covers epidemiology, diagnosis, risk stratification, and pathophysiology. Contents include coverage of the gut microbiota, ascites, and gastrointestinal bleeding as well as the challenges of hepatic encephalopathy, acute kidney injury, bacterial infections, coagulation abnormality, and venous thromboembolism, amongst others. This is the perfect resource for practicing gastroenterologists and hepatologists as well as family physicians and investigators who are skilled at the management of liver cirrhosis and its complications.

Autoren/Hrsg.

Qi, Xingshun

You, Hong

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

1. Epidemiology of liver cirrhosis.
2. Diagnosis and risk stratification of liver cirrhosis.
3. Pathophysiology of portal hypertension in liver cirrhosis.
4. Gut microbiota in liver cirrhosis.
5. Ascites in liver cirrhosis.
6. Gastrointestinal bleeding in liver cirrhosis.
7. Hepatic encephalopathy.
8. Acute kidney injury in liver cirrhosis.
9. Bacterial infections in liver cirrhosis.
10. Coagulation abnormality in liver cirrhosis.
11. Venous thromboembolism in liver cirrhosis.
12. Splenomegaly and hypersplenism in liver cirrhosis.
13. Pulmonary complications in liver cirrhosis.
14. Cirrhotic cardiomyopathy.
15. Acute-on-chronic liver failure in liver cirrhosis.
16. Hepatogenous diabetes in liver cirrhosis.
17. Nutrition in liver cirrhosis.
18. Sarcopenia in liver cirrhosis.
19. Osteoporosis in liver cirrhosis.
20. Hepatocellular carcinoma.

Über Autor(innen)

You, Hong
Hong You practices in Beijing, China. Her top areas of expertise are schistosomiasis, distomatosis, cirrhosis, hepatitis B, and liver transplant. Her clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies. She has co-authored 358 articles in peer reviewed medical journals and participated in 8 clinical trials over the past 15 years.

Qi, Xingshun
Dr. Xingshun Qi is the director at the Department of Gastroenterology of the General Hospital of Northern Theater Command. His major research interests include clinical research in the etiology, diagnosis, and management of liver cirrhosis, portal hypertension, and hepatocellular carcinoma. He is serving as a senior editorial board member of BMC Gastroenterology, an academic editor of Canadian Journal of Gastroenterology and Hepatology, an associate editor of Frontiers in Medicine, and an editorial board member of Therapeutic Advances in Gastroenterology. He has edited 11 English-language books and published more than 400 papers in peer-reviewed journals.